AI Governance for Fertility Clinics

Why fertility-clinic AI needs runtime governance

Fertility clinics adopting AI for patient communications, scheduling, clinical workflow support, and data access handle protected health information with heightened sensitivity, including cycle details, genetic results, donor identifiers, and financial records. HIPAA Privacy and Security Rules require covered entities to apply access controls, audit controls, integrity protections, and transmission security to systems that create, receive, maintain, or transmit electronic PHI. HHS OCR has also stated that HIPAA-regulated entities remain responsible for compliance when using AI tools that process PHI, including business associate agreements and appropriate safeguards.

A 2024 HHS final rule on reproductive health care privacy adds attestation requirements and tighter limits on certain uses and disclosures of PHI related to reproductive care. Automation that messages patients, exports datasets, or responds to external requests can create disclosure risk if agents act on model output without mediation. NIST AI RMF 1.0 and the Generative AI Profile further highlight risks such as privacy leakage, confabulation, and insecure plugin or tool use that can expand permissions beyond intended scope.

The enterprise problem is therefore operational, not documentary. Clinics need enforceable controls at execution time so an agent cannot bypass policy through prompt manipulation, overly broad credentials, or unreviewed tool sequences. Runtime AI governance centers on identity, permissions, policy enforcement, tool-call controls, monitoring, and auditability rather than static acceptable-use language alone.

Runtime control layers for fertility AI

Four control layers form the practical foundation for agent governance in reproductive health settings:

Workflows that require enforceable controls

Not every AI feature carries the same risk, but most agentic patterns in reproductive medicine touch systems of record. Common high-risk workflows include:

• Patient intake and messaging bots that read or write chart context
• Scheduling agents that create, move, or cancel cycle-related appointments
• Documentation assistants that pull prior notes or lab values
• Embryology or LIS summarization that surfaces genetic or laboratory results
• Prior-authorization helpers that assemble clinical packages
• Revenue-cycle agents that access billing or claims APIs

Each external action should be treated as a governed tool call: retrieve record, send message, update appointment, amend documentation, or export a dataset. Before enabling access, inventory which systems the agent can reach, which data classes those tools expose, and which purposes are approved. Field-level minimum necessary access matters. Broad human EHR roles reused for agents often overshare cycle stage, genetic markers, donor linkage, or payment details that a scheduling or messaging agent does not need.

Separate administrative AI from functions that may influence clinical decision support or regulated device behavior. FDA guidance on AI/ML-enabled device software stresses lifecycle monitoring, transparency, and predetermined change control when AI affects device or clinical decision behavior. Clinics should classify intended use early so governance, validation, and vendor due diligence match the actual risk tier.

Reference architecture for agent identity and tool governance

An effective architecture places a policy enforcement point in the agent runtime or API gateway so tool calls cannot execute if authorization fails, even when the model proposes a disallowed action. Keep policy decision separate from enforcement. Bind each decision to agent identity, session context, patient or record scope, data classification, and an approved purpose code.

Give every agent an identity distinct from human users. Identities should be cryptographically attributable and mappable to roles, delegated scopes, and environments. Prefer scoped service accounts, short-lived tokens, and per-tool allowlists over shared high-privilege credentials. Least privilege for reproductive PHI means purpose-limited and often field-limited access, not clinic-wide chart rights.

Implementation sequence for clinic technology leaders

1. Inventory workflows and classify data

Start with workflow inventory and data classification, not model selection. Map each AI use case to touchpoints across intake, scheduling, EHR, lab, messaging, and revenue cycle. Label reproductive health elements and define retention and minimum necessary fields before any agent credential is issued.

2. Define agent roles and tool allowlists

Encode deny-by-default permissions so only explicitly approved tools and parameter patterns succeed. Implement policy-as-code where practical so privacy, security, and clinical owners can review the same rules the runtime enforces. Wire human approval workflows for high-impact actions and document who may approve exceptions.

3. Operationalize audit evidence

The HIPAA Security Rule requires mechanisms that record and examine activity in systems that contain or use ePHI. For agents, audit records should support retrospective reconstruction: which agent acted, on whose authority, on which patient data, under which policy version, with what tool parameters, whether a human approved, and what outcome occurred. Store logs in append-only or otherwise tamper-evident form with retention aligned to compliance review needs.

4. Connect monitoring to incident response

Useful signals include anomalous tool sequences, bulk export attempts, cross-patient retrieval spikes, repeated policy denials, and model-proposed actions outside approved workflows. Playbooks should cover containment, credential and tool revocation, business associate and notification assessment, and post-incident policy hardening. Ownership should be explicit across clinical, privacy, security, and IT stakeholders for model updates, exception handling, and ongoing risk review in line with NIST AI RMF Govern, Map, Measure, and Manage functions.